EUCTR2007-001912-21-DK进行中（未招募）不适用
Bioavailability, Pharmacokinetics and Pharmacodynamics of Insulin Aspart following Subcutaneous Insulin Infusion (CSII) - Basal Rate Resolution.
Aarhus Sygehus, Universityhospital of Aarhus0 个研究点开始时间: 2007年5月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Type 1 diabetes mellitus (T1DM)
- •- Insulin pump users’ = 48 hours, 24 h dose < 80 U
- •- Insulin dose = 0,5 IE/kg/24hours
- •- 18 years < age < 50 years
- •- Time since diagnosis of T1DM = 5 years
- •- HbA1c = 8,5 %
- •- Safe anticonception for fertile women
- •- Being able to understand and read Danish
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Dysregulation of endocrine disorders other than type 1 diabetes mellitus
- •- Severe dysregulation of diabetes mellitus
- •- Other severe adverse disease
- •- Pregnancy, planning pregnancy, or nursing
研究者
相似试验
进行中（未招募）
不适用
Bioavailability, Pharmacokinetics and Pharmacodynamics of Insulin Aspart administered in the Duodenum in healthy volunteers – an open single blinded and uncontrolled exploratory trialDiabetes MellitusEUCTR2006-002803-15-DKAarhus Sygehus12
尚未招募
1 期
Comparative evaluation of the absorption and disposition in the body of a generic formulation of darifenacin 15 mg against the innovator product in healthy fed volunteers.Bioequivalence assessment between two formulations of darifenacin 15 mg.Other - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12610000894099Center for Clinical Pharmacology Research Bdbeq S.A.24
已完成
1 期
Comparative Bioavailability of Smartech 2% Sodium Diclofenac Topical Solution and PENNSAID 2% Applied to the Knees of Healthy Male and Female SubjectsOsteoarthritisACTRN12622001391763Avance Clinical Pty Ltd32
进行中（未招募）
1 期
A study in healthy volunteers to assess how the test medicine ODM-111 is taken up, broken down and removed from the body when taken by mouth as a tablet, and when given radiolabelled in the form of an oral solution and by short infusion into a veiISRCTN12728443Orion Corporation (Finland)8
已完成
不适用
Bioavailability and Pharmacodynamic study of Disgren EC capsule(Triflusal 300mg)Diseases of the circulatory systemKCT0001299Kyungpook National University Hospital38